您的购物车当前为空
别名 ASP8273 (mesylate)
Naquotinib mesylate (ASP8273 (mesylate)) 是一种口服的、突变体选择性和不可逆的 EGFR 抑制剂,对 EGFR 突变体和 EGFR 的 IC50值分别为8-33和230 nM。

Naquotinib mesylate (ASP8273 (mesylate)) 是一种口服的、突变体选择性和不可逆的 EGFR 抑制剂,对 EGFR 突变体和 EGFR 的 IC50值分别为8-33和230 nM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 2 mg | ¥ 497 | 5日内发货 | |
| 5 mg | ¥ 869 | 5日内发货 | |
| 100 mg | ¥ 7,890 | 6-8周 |
Naquotinib mesylate 相关产品
| 产品描述 | Naquotinib mesylate (ASP8273 (mesylate)) is an orally available, mutant-selective and irreversible inhibitor of EGFR(iC50s of 8-33 nM and 230 nM for toward EGFR mutants and EGFR). |
| 靶点活性 | EGFR:230 nM |
| 体外活性 | In NCI-H1650 (del ex19), Naquotinib inhibits cell growth with an IC50 value of 70nM while other EGFR-TKIs are only partially effective.Naquotinib selectively inhibits phosphorylation of EGFR and its down-stream signal pathway, ERK and Akt from 10nM in HCC827 and NCI-H1975 while inhibitory effects are only detected at 1000nM in A431[2]. |
| 体内活性 | In an NCI-H1975 xenograft model, complete regression of tumor is achieved after 14-days of Naquotinib treatment.?Complete regression is maintained in 50% of mice more than 85 days after cessation of Naquotinib treatment[2]. |
| 别名 | ASP8273 (mesylate) |
| 分子量 | 658.81 |
| 分子式 | C31H46N8O6S |
| CAS No. | 1448237-05-5 |
| Smiles | CS(O)(=O)=O.CCc1nc(C(N)=O)c(Nc2ccc(cc2)N2CCC(CC2)N2CCN(C)CC2)nc1O[C@@H]1CCN(C1)C(=O)C=C |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| 溶解度信息 | DMSO: 12.5 mg/mL (18.97 mM), Sonication and heating are recommended. | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||
评论内容